Mirna Therapeutics, Inc.

Synlogic Inc. has evolved into a clinical-stage public company in the span of just four months. The Cambridge, Mass.-based drug developer, pioneering a new class of living medicines that work in the

Biopharma start-up fundraising more than doubled to $3.87bn in the second quarter versus the prior quarter, helped by initial public offerings, including the Actelion Pharmaceuticals Ltd. spinout

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging bio

Rhythm Pharmaceuticals Inc. , Deciphera Pharmaceuticals LLC , NuCana PLC and Adial Pharmaceuticals Inc. all registered their intent to launch initial public offerings in September, potentially